Enovis (NYSE:ENOV – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.
Earnings & Valuation
This table compares Enovis and Innovative Eyewear”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Enovis | $2.25 billion | 0.67 | -$1.18 billion | ($19.26) | -1.35 |
| Innovative Eyewear | $2.66 million | 1.77 | -$7.59 million | ($1.69) | -0.43 |
Profitability
This table compares Enovis and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Enovis | -47.96% | 12.03% | 4.91% |
| Innovative Eyewear | -272.42% | -83.37% | -76.02% |
Analyst Ratings
This is a summary of current recommendations for Enovis and Innovative Eyewear, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Enovis | 1 | 1 | 8 | 0 | 2.70 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
Enovis presently has a consensus target price of $42.00, suggesting a potential upside of 61.02%. Given Enovis’ stronger consensus rating and higher possible upside, research analysts plainly believe Enovis is more favorable than Innovative Eyewear.
Institutional & Insider Ownership
98.5% of Enovis shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 2.9% of Enovis shares are owned by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Volatility & Risk
Enovis has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.72, indicating that its share price is 172% more volatile than the S&P 500.
Summary
Enovis beats Innovative Eyewear on 9 of the 14 factors compared between the two stocks.
About Enovis
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.com's FREE daily email newsletter.
